Data Foundry

Drug recalls 2022

Wal-Fex Fexofenadine Hydrochloride tablets — Class II drug recall D-0352-2022

Terminated recall by Perrigo Company PLC, reported 2022-01-12, distributed nationwide. Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stabi

Recall numberD-0352-2022
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmPerrigo Company PLC, Allegan, MI, United States
Recall initiated2021-07-27
Classified2022-01-05
Reported by FDA2022-01-12
Terminated2022-11-08
DistributedNationwide (US)
Quantity14,160 containers
Reason classesspecification failure
UPC / GTIN / UDI-DI00311917122670, 00311917122717, 00311917161723
NDC00363-0600-13, 00363-0600-39, 00363-0600-75
Expiration dates2022-02-28, 2022-04-30

Product

Wal-Fex Fexofenadine Hydrochloride tablets, 180mg/antihistamine, 24HR, packaged as a) 5 count bottle, NDC 0363-0600-13,UPC 3 11917 12267 0, b)30 count bottle, NDC 0363-0600-39 UPC 3 11917 16172 3 c) 90 count bottle, NDC 0363-0600-75 UPC 3 11917 12271 7 ; Distributed by Walgreen Co. 200 Wilmot Rd Deerfield IL 60015, Made in the Czech Republic,

Reason for recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0352-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.